# Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH

> **NCT02976012** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Southeast Retina Center, Georgia** · enrollment: 24 (estimated)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** Aflibercept
- **PROCEDURE:** Endolaserless Vitrectomy

## Key facts

- **NCT ID:** NCT02976012
- **Lead sponsor:** Southeast Retina Center, Georgia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2016-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976012, "Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02976012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*